Previous 10 | Next 10 |
2024-01-23 08:25:53 ET More on Pre-market losers & stocks. Mesoblast Has Major Hurdles Holding The Fort: Mesoblast's Path Towards Overcoming FDA Rejection Mesoblast rises after cell therapy gets FDA rare pediatric disease designation MSP Recovery stock tu...
2024-01-22 12:31:12 ET Gainers: Sagimet Biosciences ( SGMT ) +106% . Rail Vision Ltd ( RVSN ) +51% . Digital World Acquisition Corp ( DWAC ) +49% . Bullfrog AI Holdings ( BFRG ) +38% . CXApp ( CXAI ) +34% . Phunware ( PHUN ...
2024-01-18 13:35:16 ET More on Mid-day movers & stocks. Phunware, Inc. (PHUN) Q3 2023 Earnings Call Transcript Jasper Therapeutics to effect 1-for-10 reverse stock split Phunware Q3 2023 Earnings Preview Seeking Alpha’s Quant Rating on Jasper Thera...
2024-01-18 10:00:02 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Healthcare had the largest net buying in five months - Goldman Health stocks to watch ...
2024-01-18 09:18:57 ET More on Panbela Therapeutics Panbela Therapeutics, Inc. (PBLA) Q3 2023 Earnings Call Transcript Panbela announces 1-for-20 reverse stock split Panbela Therapeutics announces exercise of existing warrants Seeking Alpha’s Quant Rat...
MINNEAPOLIS, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc . (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs announces the publication of clinical data from studies of CPP-1...
2024-01-17 08:02:09 ET Panbela Therapeutics Inc (PBLA) announced stock split at a ratio of 1-for-20 on 2024-01-18 ... Full story available on KlickAnalytics.com
2024-01-16 08:21:22 ET More on Panbela Therapeutics Panbela Therapeutics announces exercise of existing warrants Seeking Alpha’s Quant Rating on Panbela Therapeutics Historical earnings data for Panbela Therapeutics Financial information for Panbela Th...
MINNEAPOLIS, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will implement the previously announced and stoc...
2023-12-21 12:18:35 ET Gainers: Infrared Cameras Holdings ( MSAI ) +195% . Mullen Automotive ( MULN ) +112% . Baijiayun Group Ltd ( RTC ) +33% . HeartBeam ( BEAT ) +31% . Triumph Group ( TGI ) +32% . TC BioPharm ( TCBP ) ...
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced an Issue Notification for the US continuation patent US 11,925,613 B2 ...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
MINNEAPOLIS, May 01, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will host a conference call on Ma...